[Effect of the optimal dose of finoptin on various components of the circulatory system in heart failure in patients with ischemic heart disease].
Following sublingual finoptin and following its course therapy, 27 patients with coronary heart disease in the presence of Stages I-IIA circulatory failure displayed positive central hemodynamic changes, myocardial contractile function improvement, afterload decrease, and a tendency to normalization of vascular and intravascular alterations.
Denisiuk
V I
VI
Belokonnaia
N S
NS
D000286:Administration, Sublingual; D000328:Adult; D000368:Aged; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D003327:Coronary Disease / Q000150:complications* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects* / Q000502:physiology; D014700:Verapamil / Q000008:administration & dosage / Q000627:therapeutic use*
D014700:Verapamil
Vliianie finoptina v optimal'no podobrannykh dozakh na razlichnye zven'ia sistemy krovoobrashcheniia pri serdechnoĭ nedostatochnosti u bol'nykh ishemicheskoĭ bolezn'iu serdtsa.